Metraipolis › archive › dc_2d6142adb280

Comparative effectiveness of omalizumab in asthma-COPD overlap vs. asthma: a retrospective cohort study — Europe PMC PMID:41647517

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41647517
DOI
10.3389/fmed.2026.1738610
License (as archived)
solo-consultazione
Archived
2026-11-06T15:28:35.067Z
SHA-256 of the archived text
ea295875fa84bdc61707df2d4125aa76b42cfd7d751d4cf79e5d093650a186b6
Stable URL of this page
https://metraipolis.com/documento/dc_2d6142adb280

How to cite

Comparative effectiveness of omalizumab in asthma-COPD overlap vs. asthma: a retrospective cohort study — Europe PMC PMID:41647517 — Europe PMC (en), https://europepmc.org/article/MED/41647517 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2d6142adb280 (Metraipolis archive dc_2d6142adb280, sha256 ea295875fa84bdc61707df2d4125aa76b42cfd7d751d4cf79e5d093650a186b6)
BibTeX
@misc{dc2d6142adb280,
  title = {Comparative effectiveness of omalizumab in asthma-COPD overlap vs. asthma: a retrospective cohort study — Europe PMC PMID:41647517},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41647517},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2d6142adb280; sha256 ea295875fa84bdc61707df2d4125aa76b42cfd7d751d4cf79e5d093650a186b6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41647517. Agents can read the archived copy with the MCP tool read_document.